haloperidol has been researched along with Hyperactivity, Motor in 79 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Evaluation of (+)-22a in animal models of schizophrenia-related behaviors revealed that it had a desirable activity profile, as it reduced d-amphetamine-stimulated hyperlocomotion in the open field test, it restored d-amphetamine-disrupted prepulse inhibition, it induced cognitive improvements in the novel object recognition memory test in NR1-KD animals, and it produced very little catalepsy relative to haloperidol." | 3.83 | Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models. ( Cheng, J; Giguere, PM; Huang, XP; Kozikowski, AP; McCorvy, JD; Pogorelov, VM; Rodriguiz, RM; Roth, BL; Schmerberg, CM; Wetsel, WC; Zhu, H, 2016) |
| "Activated lipid peroxidation observed in brain homogenates in experimental choreoid hyperkinesis and bemegride epilepsy can be arrested by antioxidant pretreatment." | 3.69 | [The role of lipid peroxidation in the pathogenesis of neuropathological syndromes and in experimental therapy]. ( Aliev, AN; Aliev, MN; Mamedbeĭli, TN; Rzaev, RN, 1994) |
| "Either L-dopa, in combination with 1-alpha-methyldopa hydrazine (MK-486), or 1-(2''-pyrimidyl)-4-piperonylpiperazine, an agent that stimulates dopamine receptors, relieves surgically induced tremor in monkeys and concomitantly evokes involuntary movements." | 3.65 | Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent. ( Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Ohmoto, T, 1973) |
| "Treatment with haloperidol or LY379268 normalized novelty-induced locomotor hyperactivity in GLAST KO." | 1.35 | Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. ( Heilig, M; Holmes, A; Karlsson, RM; Tanaka, K, 2008) |
| "Aripiprazole is an atypical antipsychotic that acts as a partial agonist at the dopamine D(2) receptor." | 1.35 | Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice. ( Guimarães, FS; Leite, JV; Moreira, FA, 2008) |
| " In addition the home cage behaviour of mice administered with the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) using an acute dosing regimen was also investigated." | 1.33 | Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration. ( Billinton, A; Brown, M; Chapman, H; Quinn, LP; Stean, TO; Upton, N; Vidgeon-Hart, M; Virley, DJ, 2006) |
| " Thus, for example, NT69L after five daily injections at a fixed dosage was as effective at reversing cocaine-induced hyperactivity as after the first injection." | 1.32 | Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier. ( Boules, M; Fauq, A; McCormick, D; McMahon, B; Richelson, E; Stewart, J; Wang, R; Warrington, L; Yerbury, S, 2003) |
| " While typical antipsychotics are often switched to atypical agents when adverse effects become limiting, there is little preclinical information to support this strategy, both in terms of efficacy and side effects." | 1.32 | Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. ( Matsuoka, N; Mutoh, S; Shirakawa, K; Tada, M, 2004) |
| "When haloperidol 2 mg/kg was administered i." | 1.31 | Dopaminergic neurotransmission triggers ischemia-induced hyperactivity in Mongolian gerbils. ( Araki, H; Futagami, K; Gomita, Y; Kawasaki, H; Yamamoto, T, 2001) |
| "A model of hyperkinesia in the rat, exaggerated paw treading triggered by oral sensory stimulation, has been reported previously to result from lesions of the globus pallidus or ventral pallidum/substantia innominata." | 1.30 | Haloperidol decreases hyperkinetic paw treading induced by globus pallidus lesions in the rat. ( Berridge, KC; Cromwell, HC, 1997) |
| "Gilles de la Tourette syndrome is frequently associated with symptoms characteristic of hyperactivity and often goes unrecognized for long periods of time." | 1.26 | Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome. ( Sleator, EK, 1980) |
| "Treatment with haloperidol in all patients and with dipropylacetic acid in three patients did not appear to modify the CSF, HVA, and 5HIAA concentrations, the plasma DBH activity, or the DA uptake." | 1.26 | Biochemical aspects of Huntington's chorea. ( Algeri, S; Branciforti, A; Calderini, G; Caraceni, T; Consolazione, A; Dall'olio, A; Girotti, F; Morselli, PL; Riva, E; Spreafico, R, 1977) |
| "Gilles de la Tourette's syndrome was independently ascertained in two male cousins once removed." | 1.26 | Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy. ( Cohen, NL; Friedhoff, AJ; Pollack, MA, 1977) |
| "We conclude that phenytoin induced hyperkinesias reflect a specific effect of phenytoin on an abnormal neural substrate and suggest the presence of an otherwise silent pathological alteration of the corpus striatum." | 1.26 | Clinical and experimental studies of phenytoin-induced hyperkinesias. ( Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ, 1979) |
| "The hyperkinesia was antagonized by phenoxybenzamine (an alpha-adrenergic receptor antagonist) and by FLA-63 (a dopamine-beta-hydroxylase inhibitor) but not by haloperidol (a dopamine receptor antagonist)." | 1.26 | The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline. ( Dunstan, R; Jackson, DM; Perrington, A, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (51.90) | 18.7374 |
| 1990's | 12 (15.19) | 18.2507 |
| 2000's | 20 (25.32) | 29.6817 |
| 2010's | 5 (6.33) | 24.3611 |
| 2020's | 1 (1.27) | 2.80 |
| Authors | Studies |
|---|---|
| de Paulis, T | 1 |
| Kumar, Y | 1 |
| Johansson, L | 1 |
| Rämsby, S | 1 |
| Florvall, L | 1 |
| Hall, H | 1 |
| Angeby-Möller, K | 1 |
| Ogren, SO | 2 |
| Taverne, T | 1 |
| Diouf, O | 1 |
| Depreux, P | 1 |
| Poupaert, JH | 1 |
| Lesieur, D | 1 |
| Guardiola-Lemaître, B | 1 |
| Renard, P | 1 |
| Rettori, MC | 1 |
| Caignard, DH | 1 |
| Pfeiffer, B | 1 |
| Cheng, J | 1 |
| Giguere, PM | 1 |
| Schmerberg, CM | 1 |
| Pogorelov, VM | 1 |
| Rodriguiz, RM | 1 |
| Huang, XP | 1 |
| Zhu, H | 1 |
| McCorvy, JD | 1 |
| Wetsel, WC | 1 |
| Roth, BL | 1 |
| Kozikowski, AP | 1 |
| Lages, YV | 1 |
| Maisonnette, SS | 1 |
| Rosseti, FP | 1 |
| Galvão, BO | 1 |
| Landeira-Fernandez, J | 1 |
| Sun, T | 3 |
| Liu, X | 1 |
| Li, M | 3 |
| Boerner, T | 1 |
| Bygrave, AM | 1 |
| Chen, J | 1 |
| Fernando, A | 1 |
| Jackson, S | 1 |
| Barkus, C | 1 |
| Sprengel, R | 1 |
| Seeburg, PH | 1 |
| Harrison, PJ | 1 |
| Gilmour, G | 1 |
| Bannerman, DM | 1 |
| Sanderson, DJ | 1 |
| Karlsson, RM | 1 |
| Tanaka, K | 1 |
| Heilig, M | 1 |
| Holmes, A | 1 |
| Maehara, S | 1 |
| Hikichi, H | 1 |
| Satow, A | 1 |
| Okuda, S | 1 |
| Ohta, H | 1 |
| Hu, G | 1 |
| van der Staay, FJ | 1 |
| Pouzet, B | 2 |
| Mahieu, M | 1 |
| Nordquist, RE | 1 |
| Schuurman, T | 1 |
| Hidaka, N | 1 |
| Suemaru, K | 1 |
| Araki, H | 2 |
| Zhao, C | 1 |
| Garris, PA | 1 |
| Budygin, EA | 1 |
| Phillips, PE | 1 |
| Venton, BJ | 1 |
| Robinson, DL | 1 |
| Bergstrom, BP | 1 |
| Rebec, GV | 1 |
| Wightman, RM | 1 |
| O'Neill, MF | 1 |
| Heron-Maxwell, C | 1 |
| Conway, MW | 1 |
| Monn, JA | 1 |
| Ornstein, P | 1 |
| Boules, M | 1 |
| McMahon, B | 1 |
| Wang, R | 1 |
| Warrington, L | 1 |
| Stewart, J | 1 |
| Yerbury, S | 1 |
| Fauq, A | 1 |
| McCormick, D | 1 |
| Richelson, E | 1 |
| Tada, M | 1 |
| Shirakawa, K | 1 |
| Matsuoka, N | 1 |
| Mutoh, S | 1 |
| Coppola, G | 1 |
| Morelli, E | 1 |
| Bravaccio, C | 1 |
| Federico, R | 1 |
| Gritti, A | 1 |
| Nilsson, M | 2 |
| Carlsson, A | 2 |
| Markinhuhta, KR | 1 |
| Sonesson, C | 1 |
| Pettersson, F | 1 |
| Gullme, M | 1 |
| Carlsson, ML | 2 |
| Lautar, SL | 1 |
| Rojas, C | 1 |
| Slusher, BS | 1 |
| Wozniak, KM | 1 |
| Wu, Y | 1 |
| Thomas, AG | 1 |
| Waldon, D | 1 |
| Li, W | 1 |
| Ferraris, D | 1 |
| Belyakov, S | 1 |
| Dall'Igna, OP | 1 |
| Tort, AB | 1 |
| Souza, DO | 1 |
| Lara, DR | 1 |
| Fredriksson, A | 1 |
| Eriksson, P | 1 |
| Archer, T | 1 |
| Quinn, LP | 1 |
| Stean, TO | 1 |
| Chapman, H | 1 |
| Brown, M | 1 |
| Vidgeon-Hart, M | 1 |
| Upton, N | 1 |
| Billinton, A | 1 |
| Virley, DJ | 1 |
| Leite, JV | 1 |
| Guimarães, FS | 1 |
| Moreira, FA | 1 |
| Schiele, B | 1 |
| Cools, AR | 2 |
| van Rossum, JM | 1 |
| Lin, MT | 1 |
| Chan, HK | 1 |
| Chen, CF | 1 |
| Teh, GW | 1 |
| Ushijima, I | 1 |
| Yamada, K | 1 |
| Noda, Y | 1 |
| Furukawa, T | 1 |
| Morgenstern, R | 1 |
| Fink, H | 1 |
| Oelssner, W | 1 |
| Clementi, G | 1 |
| Prato, A | 1 |
| Bernardini, R | 1 |
| Nicoletti, F | 1 |
| Patti, F | 1 |
| De Simone, D | 1 |
| Scapagnini, U | 1 |
| Castillo, J | 1 |
| Castro, A | 1 |
| Dapena, D | 1 |
| Arias, M | 1 |
| Colell, S | 1 |
| Lema, M | 1 |
| Noya, M | 1 |
| Schechter, MD | 1 |
| Concannon, JT | 1 |
| Sleator, EK | 1 |
| Köhler, C | 1 |
| Haglund, L | 1 |
| Angeby, T | 1 |
| Aliev, MN | 1 |
| Rzaev, RN | 1 |
| Mamedbeĭli, TN | 1 |
| Aliev, AN | 1 |
| Gay, J | 1 |
| Losa, JE | 1 |
| Iglesias-Osma, C | 1 |
| Ortín, A | 1 |
| Iakimovskiĭ, AF | 1 |
| Ouagazzal, A | 1 |
| Amalric, M | 1 |
| Fang, J | 1 |
| Cromwell, HC | 1 |
| Berridge, KC | 1 |
| Furuya, Y | 1 |
| Kagaya, T | 1 |
| Nishizawa, Y | 1 |
| Ogura, H | 1 |
| Ninan, I | 1 |
| Kulkarni, SK | 1 |
| Martin, P | 1 |
| Sorensen, SM | 1 |
| Waters, S | 1 |
| Waters, N | 1 |
| Maj, J | 1 |
| Rogóz, Z | 1 |
| Skuza, G | 1 |
| Bast, T | 1 |
| Zhang, WN | 1 |
| Heidbreder, C | 1 |
| Feldon, J | 1 |
| Andersen, MP | 1 |
| Yamamoto, T | 1 |
| Futagami, K | 1 |
| Kawasaki, H | 1 |
| Gomita, Y | 1 |
| Stalman, SL | 1 |
| Turrone, P | 1 |
| Remington, G | 1 |
| Nobrega, JN | 1 |
| Winsberg, BG | 1 |
| Yepes, LE | 1 |
| Bialer, I | 1 |
| Heath, A | 1 |
| Caraceni, T | 1 |
| Calderini, G | 1 |
| Consolazione, A | 1 |
| Riva, E | 1 |
| Algeri, S | 1 |
| Girotti, F | 1 |
| Spreafico, R | 1 |
| Branciforti, A | 1 |
| Dall'olio, A | 1 |
| Morselli, PL | 1 |
| Pollack, MA | 1 |
| Cohen, NL | 1 |
| Friedhoff, AJ | 1 |
| Badalian, LO | 1 |
| Skvortsov, IA | 1 |
| Kamennykh, LN | 1 |
| Dadali, EL | 1 |
| Temin, PA | 1 |
| Feinberg, M | 1 |
| Carroll, BJ | 1 |
| Oldham, AJ | 2 |
| Nausieda, PA | 1 |
| Koller, WC | 1 |
| Weiner, WJ | 1 |
| Klawans, HL | 1 |
| Kuczenski, R | 1 |
| Schmidt, D | 1 |
| Leith, N | 1 |
| Pert, A | 1 |
| Sivit, C | 1 |
| Langlais, PJ | 1 |
| Gabay, S | 1 |
| Jackson, DM | 1 |
| Dunstan, R | 1 |
| Perrington, A | 1 |
| Werry, JS | 4 |
| Aman, MG | 4 |
| Lampen, E | 1 |
| Dowrick, PW | 1 |
| Raeburn, JM | 1 |
| Barker, P | 1 |
| Malyshev, IuI | 1 |
| Grabowski, SW | 1 |
| Kivalo, E | 1 |
| Weckman, N | 1 |
| Ott, J | 1 |
| Müller, E | 1 |
| Heidrich, R | 1 |
| Snyder, SH | 1 |
| Taylor, KM | 1 |
| Coyle, JT | 1 |
| Meyerhoff, JL | 1 |
| Arushanian, EB | 1 |
| Golden, GS | 1 |
| Goldstein, M | 1 |
| Battista, AF | 1 |
| Ohmoto, T | 1 |
| Anagnoste, B | 1 |
| Fuxe, K | 1 |
| Nagyová, H | 1 |
| Novotný, V | 1 |
| Tewfik, GI | 1 |
| Jain, VK | 1 |
| Harcup, M | 1 |
| Magowan, S | 1 |
| Bott, M | 1 |
| Gurovich, IIa | 1 |
| Fleĭs, EP | 1 |
4 reviews available for haloperidol and Hyperactivity, Motor
| Article | Year |
|---|---|
Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Behavior, Animal; Brain; Cats; Corpus Striatum; Dextroamphe | 1980 |
The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?
Topics: Animals; Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Humans; | 2002 |
Psychiatric drug treatment in children.
Topics: Adolescent; Amphetamines; Antipsychotic Agents; Anxiety; Autistic Disorder; Behavior Therapy; Child; | 1979 |
[The role of dopamine in the physiology and pathology of the basal ganglia].
Topics: Basal Ganglia; Brain; Caudate Nucleus; Chlorpromazine; Corpus Striatum; Dihydroxyphenylalanine; Dopa | 1972 |
6 trials available for haloperidol and Hyperactivity, Motor
| Article | Year |
|---|---|
Effects of dopamine agonists and antagonists in Tourette's disease.
Topics: Adolescent; Adult; Amphetamine; Apomorphine; Child; Clinical Trials as Topic; Dextroamphetamine; Dop | 1979 |
Haloperidol and methylphenidate in hyperactive children.
Topics: Child; Child, Preschool; Clinical Trials as Topic; Cognition; Dose-Response Relationship, Drug; Drug | 1976 |
Methylphenidate and haloperidol in children. Effects on attention, memory, and activity.
Topics: Aggression; Attention; Child; Child, Preschool; Clinical Trials as Topic; Cognition; Dose-Response R | 1975 |
The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action.
Topics: Analysis of Variance; Blood Pressure; Child; Clinical Trials as Topic; Digestion; Female; Haloperido | 1975 |
Safety and effectiveness of haloperidol for mentally retarded behaviorally disordered and hyperkinetic patients.
Topics: Adolescent; Adult; Affective Symptoms; Aged; Benztropine; Child; Clinical Trials as Topic; Female; H | 1973 |
Effectiveness of various tranquilisers in the management of senile restlessness.
Topics: Aged; Carbamates; Chlorpromazine; Clinical Trials as Topic; Dementia; Female; Haloperidol; Humans; H | 1970 |
69 other studies available for haloperidol and Hyperactivity, Motor
| Article | Year |
|---|---|
Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides.
Topics: Animals; Apomorphine; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine Antagonis | 1985 |
Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Cattle; Corpus Striatum; Dopamine Agen | 1998 |
Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.
Topics: Animals; Brain; Catalepsy; Central Nervous System Stimulants; Cognition; Dextroamphetamine; Drug Des | 2016 |
Haloperidol and methylphenidate alter motor behavior and responses to conditioned fear of Carioca Low-conditioned Freezing rats.
Topics: Animals; Anxiety; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Conditioning, Psy | 2021 |
Effect of environmental cues on the behavioral efficacy of haloperidol, olanzapine, and clozapine in rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Cues; Drug Tolerance; Environment; Excita | 2014 |
The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout mice.
Topics: Animals; Bridged Bicyclo Compounds; Dopamine Antagonists; Excitatory Amino Acid Agonists; Female; Ha | 2017 |
Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist.
Topics: Amino Acids; Analysis of Variance; Animals; Anti-Dyskinesia Agents; Behavior, Animal; Bridged Bicycl | 2008 |
Antipsychotic property of a muscarinic receptor agonist in animal models for schizophrenia.
Topics: Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Dose-Response Relations | 2008 |
Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Clozapine; Disease Models, Animal; | 2009 |
The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics.
Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship | 2009 |
Serotonin-dopamine antagonism ameliorates impairments of spontaneous alternation and locomotor hyperactivity induced by repeated electroconvulsive seizures in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Dopamine Antagonists; Electroshock; Haloperidol; Hy | 2010 |
Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain; Clozapine; Haloperidol; Hyperkinesis; Male; | 2012 |
A role for presynaptic mechanisms in the actions of nomifensine and haloperidol.
Topics: Animals; Autoreceptors; Brain; Catalepsy; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane T | 2003 |
Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.
Topics: Amino Acids; Animals; Benzazepines; Dizocilpine Maleate; Dopamine Antagonists; Dose-Response Relatio | 2003 |
Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
Topics: Amphetamine; Animals; Behavior, Animal; Blood Glucose; Blood-Brain Barrier; Body Temperature; Brain; | 2003 |
Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Oral; Animals; Antipsychotic Agents; Basal G | 2004 |
Unusual compulsive motor activity during treatment with clothiapine in a mentally retarded adolescent.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Compulsive Be | 2004 |
The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition.
Topics: Animals; Autistic Disorder; Behavior, Animal; Cognition; Dizocilpine Maleate; Dopamine Antagonists; | 2004 |
DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice.
Topics: Amphetamine; Animals; Aza Compounds; Azetidines; Behavior, Animal; Diabetes Mellitus; Dipeptidyl-Pep | 2005 |
Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
Topics: Amphetamine; Animals; Antipsychotic Agents; Calcium Channel Blockers; Catalepsy; Central Nervous Sys | 2005 |
Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice.
Topics: Animals; Antipsychotic Agents; Apomorphine; Basal Ganglia; Clozapine; Dopamine Agonists; Drug Intera | 2006 |
Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Apomorphine; Automation; Behavio | 2006 |
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Central Nervous System Stimulan | 2008 |
[Therapeutic profile of haloperidol].
Topics: Agranulocytosis; Antipsychotic Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug | 1980 |
Involvement of both opiate and catecholaminergic receptors in the behavioural excitation provoked by thyrotropin-releasing hormone: comparisons with amphetamine.
Topics: Amphetamine; Animals; Behavior, Animal; Haloperidol; Humans; Hyperkinesis; Male; Naloxone; Propranol | 1983 |
Progressive augmentation of locomotor activity in mice by long-term treatment with thyrotropin releasing hormone.
Topics: Animals; Apomorphine; Drug Interactions; Haloperidol; Humans; Hyperkinesis; Injections, Subcutaneous | 1984 |
LSD-potentiated apomorphine hypermotility: a model for differentiating antipsychotic drugs.
Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Disease Models, Animal; Drug Antagonism; Haloperido | 1983 |
Effects of calcitonin on the brain of aged rats.
Topics: Age Factors; Animals; Apomorphine; Calcitonin; Catalepsy; Drug Synergism; Extrapyramidal Tracts; Hal | 1983 |
[Clinical and electrophysiological study of idiopathic orofacial dystonia (Meige's disease or Brueghel syndrome)].
Topics: Dystonia; Electromyography; Facial Expression; Facial Muscles; Female; Haloperidol; Humans; Hyperkin | 1984 |
Haloperidol-induced hyperactivity in neonatal rats: effect of lithium and stimulants.
Topics: Animals; Animals, Newborn; Dextroamphetamine; Disease Models, Animal; Female; Haloperidol; Humans; H | 1982 |
Deleterious effects of drugs used for hyperactivity on patients with Gilles de la Tourette syndrome.
Topics: Child; Haloperidol; Humans; Hyperkinesis; Male; Methylphenidate; Pemoline; Tourette Syndrome | 1980 |
Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
Topics: Animals; Apomorphine; Binding, Competitive; Brain; Butyrophenones; Chlorpromazine; Clozapine; Halope | 1981 |
[The role of lipid peroxidation in the pathogenesis of neuropathological syndromes and in experimental therapy].
Topics: Animals; Antioxidants; Bemegride; Brain Chemistry; Chorea; Disease Models, Animal; Drug Evaluation, | 1994 |
[Hemichorea-hemiballismus syndrome worsened by haloperidol].
Topics: Aged; Chorea; Female; Haloperidol; Humans; Hyperkinesis; Syndrome | 1994 |
[The effect of the activation and blockade of the neostriatal dopaminergic system on the hyperkinesis evoked in rats by the intrastriatal administration of picrotoxin].
Topics: Amphetamine; Animals; Chorea; Haloperidol; Hyperkinesis; Male; Metoclopramide; Microinjections; Myoc | 1993 |
Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
Topics: 2-Amino-5-phosphonovalerate; Animals; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Dose-Resp | 1995 |
Hyperactive behavioural effects induced by intranigral infusion of a pyridinium metabolite of haloperidol in rats.
Topics: Animals; Behavior, Animal; Dystonia; Haloperidol; Hyperkinesis; Injections, Intraventricular; Male; | 1996 |
Haloperidol decreases hyperkinetic paw treading induced by globus pallidus lesions in the rat.
Topics: Animals; Behavior, Animal; Dopamine Antagonists; Forelimb; Globus Pallidus; Haloperidol; Hyperkinesi | 1997 |
Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine Agonists; Drug Evaluation, Preclinical; Excitat | 1998 |
Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Benzazepines; Clozapine; Dizocilpine Maleate; D | 1998 |
Serotonin: a behaviorally active compound in the caudate nucleus of cats.
Topics: Animals; Athetosis; Autonomic Agents; Behavior, Animal; Carbachol; Cats; Caudate Nucleus; Compulsive | 1973 |
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Topics: Amphetamine; Animals; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; | 1999 |
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Agents; Dopam | 1999 |
Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine.
Topics: Animals; Clozapine; Dopamine Antagonists; Excitatory Amino Acid Agonists; Haloperidol; Hippocampus; | 2001 |
Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimula | 2001 |
Dopaminergic neurotransmission triggers ischemia-induced hyperactivity in Mongolian gerbils.
Topics: Animals; Brain Ischemia; Dopamine; Dopamine Antagonists; Gerbillinae; Haloperidol; Hyperkinesis; Inj | 2001 |
Prevention of relapse in schizophrenia.
Topics: Antipsychotic Agents; Haloperidol; Humans; Hyperkinesis; Psychomotor Agitation; Risperidone; Schizop | 2002 |
Pharmacologic management of children with hyperactive/aggressive/inattentive behavior disorders. Suggestions for the pediatrician.
Topics: Age Factors; Aggression; Antidepressive Agents, Tricyclic; Attention; Central Nervous System Stimula | 1976 |
Biochemical aspects of Huntington's chorea.
Topics: Adult; Age Factors; Blood Platelets; Brain Damage, Chronic; Dopamine; Dopamine beta-Hydroxylase; Fem | 1977 |
Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy.
Topics: Adult; Child; Dextroamphetamine; Haloperidol; Humans; Hyperkinesis; Male; Methylphenidate; Pedigree; | 1977 |
[Generalized paroxysmal tic (Tourette's syndrome)].
Topics: Adolescent; Adult; Catecholamines; Child; Diagnosis, Differential; Electromyography; Female; Haloper | 1979 |
[Rapid control of the acute patient by haloperidol administration].
Topics: Acute Disease; England; Haloperidol; History, 20th Century; Humans; Hyperkinesis; Injections, Intram | 1979 |
Clinical and experimental studies of phenytoin-induced hyperkinesias.
Topics: Aged; Animals; Apomorphine; Basal Ganglia; Corpus Striatum; Dextroamphetamine; Disease Models, Anima | 1979 |
Amphetamine-haloperidol interactions in rat striatum: failure to correlate behavioral effects with dopaminergic and cholinergic dynamics.
Topics: Amphetamine; Animals; Behavior, Animal; Catalepsy; Choline; Corpus Striatum; Dopamine; Drug Interact | 1977 |
Neuroanatomical focus for morphine and enkephalin-induced hypermotility.
Topics: Animals; Apomorphine; Dopamine; Drug Interactions; Enkephalins; Haloperidol; Humans; Hyperkinesis; I | 1977 |
Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
Topics: Animals; Behavior, Animal; Brain; Dopamine; Female; Haloperidol; Humans; Hyperkinesis; Methysergide; | 1977 |
The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Dopamine; Dose-Response Relationship, | 1979 |
Video editing and medication to produce a therapeutic self model.
Topics: Behavior Therapy; Child, Preschool; Haloperidol; Humans; Hyperkinesis; Intellectual Disability; Male | 1977 |
The reliability and diagnostic validity of the physical and neurological examination for soft signs (PANESS).
Topics: Brain Damage, Chronic; Child; Child, Preschool; Evaluation Studies as Topic; Haloperidol; Humans; Hy | 1976 |
Haloperidol.
Topics: Child; Child, Preschool; Haloperidol; Humans; Hyperkinesis; Intellectual Disability; Stuttering; Tic | 1975 |
[Problems of diagnosis and treatment of deforming muscular dystrophy in children].
Topics: Child; Diagnosis, Differential; Drug Therapy, Combination; Haloperidol; Hand Deformities, Acquired; | 1990 |
[Use of haloperidol in the treatment of extrapyramidal compulsive movement].
Topics: Adult; Aged; Chorea; Extrapyramidal Tracts; Female; Haloperidol; Humans; Huntington Disease; Hyperki | 1970 |
[Differential diagnosis of acute extrapyramidal motor disorders in children. A case study].
Topics: Acute Disease; Adolescent; Basal Ganglia Diseases; Diagnosis, Differential; Female; Haloperidol; Hep | 1974 |
The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs.
Topics: Amphetamine; Animals; Behavior; Brain; Brain Chemistry; Compulsive Behavior; Dopamine; Haloperidol; | 1970 |
Gilles de la Tourette's syndrome following methylphenidate administration.
Topics: Age Factors; Child; Dopamine; Haloperidol; Humans; Hyperkinesis; Male; Methylphenidate; Neurologic M | 1974 |
Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
Topics: 5-Hydroxytryptophan; Animals; Benzyl Compounds; Dihydroxyphenylalanine; Dioxoles; Drug Interactions; | 1973 |
Drug treatment of tic and hyperkinesia in children.
Topics: Child; Child Behavior Disorders; Child, Preschool; Haloperidol; Humans; Hyperkinesis; Tic Disorders | 1973 |
The management of excitement in a general hospital psychiatric ward by high dosage haloperidol.
Topics: Administration, Oral; Adult; Aggression; Evaluation Studies as Topic; Female; Haloperidol; Hospitals | 1971 |
[A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
Topics: Aged; Bipolar Disorder; Chlorpromazine; Chronic Disease; Extrapyramidal Tracts; Female; Haloperidol; | 1969 |